PEBP1 and prostate cancer: However, Beach et al. showed that 5-AzaC treatment did not induce RKIP expression in the prostate cancer cell line DU145, even though the HDAC inhibitor trichostatin A (TSA) caused a potent increase in RKIP levels [25].